Skip to main content
Pharmacogenomics and Personalized Medicine logoLink to Pharmacogenomics and Personalized Medicine
. 2009 Aug 21;2:49–57. doi: 10.2147/pgpm.s5850

Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island

Thouraya Baroudi Ouederni 1, Ahmed Fadiel 2,3, Nejla Stambouli 1, Trudy J Scalize 3, Hedi Ben Maiz 4, Hafaona Kammoun Abid 1, Rim Bouhaha 1, Jose Sanchez-Corona 5, Adel Hamza 1,6,✉,*, Amel Benammar-Elgaaied 1,*
PMCID: PMC3513201  PMID: 23226034

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by three major metabolic abnormalities: impaired insulin-stimulated glucose uptake in muscle and adipose tissues, alterations in glucose-stimulated insulin secretion, and increased hepatic glucose production. Both genetic and environmental factors contribute to its development. The insulin gene (INS), insulin receptor gene (INSR), and insulin receptor substrate 1 gene (IRS1), identified by polymerase chain reaction and digestion with selected restriction enzymes PstI, NsiI, and BstnI, have been proposed as T2DM candidate genes. To determine the contribution of genetic and environmental factors on the occurrence of T2DM, we examined the frequency of T2DM among two ethnically diverse populations, Arabs and Berbers, who have shared the same environment, the island of Djerba, for thousands of years. Both populations have a high prevalence of obesity,T2DM, and a high consanguinity rate. A total of 162 T2DM men and women were matched to 110 healthy male and female controls. Results showed that the NsiI polymorphism in INSR and BstnI polymorphism of IRS1 were significantly associated with T2DM only among the Berber group. The PstI polymorphism in INS, was not associated with T2DM in either group. Sedentary lifestyles, lower physical activity, and lower educational levels were associated with T2DM among the Berber group. These findings suggest that the insulin receptor gene and lifestyle factors in combination may contribute to the occurrence of T2DM in the Berber portion of this island population.

Keywords: polymorphism, insulin, insulin receptor, lifestyle, insulin receptor substrate-1, Berbers, Arabs, Djerba Island

Introduction

Type 2 diabetes mellitus (T2DM) is a multifactorial disease resulting from an interaction between genetic and environmental factors.1 Age, physical activity patterns, dietary habits, lifestyle and obesity play a crucial role in the modulation of the disease occurrence. The predisposition to this disease is thought to be conferred by a number of different genes that in isolation may have only minor effects, but in combination lead to the characteristic pathophysiological effects.2 This genetic susceptibility may be conferred by an unfavorable combination of individual polymorphisms in the genes involved, each one controlling part of the pathogenic process.3 These genes are defined as “diabetogenes”48 many of which encode proteins of a functional complex that play a key role in glucose metabolism and others involved in the signal transduction characterizing insulin’s biological activity.8 These genes are the insulin gene (INS), the insulin receptor gene (INSR), and the insulin receptor substrate 1 gene (IRS1)5 in which several polymorphisms (single-nucleotide polymorphisms [SNPs]) have been described. Some of these SNPs have been associated with T2DM. A polymorphism of interest in the INS gene is the PstI RFLP at position 1367 of the 3′ untranslated region.9,10 In the INSR gene, the NsiI RFLP at exon 8, has been associated with arterial hypertension.11 Finally, the IRS1 gene presents a polymorphism located at codon 972 (Bstn I RFLP),12 which has been associated with both T2DM and insulin resistance.12,13

Studies have investigated polymorphisms associated with T2DM and found that among heterogeneous populations throughout the world, there are similar polymorphisms that convey genetic risks for T2DM in subgroups of main populations, ie, Mexican Americans, Pima Indians, gypsies of southern Slovakia, African Americans, to name a few. This feature has been reported in cases of isolated ethnic groups1418 and among disadvantaged groups in developed countries.19

Here we focus on well defined neighboring populations belonging to two ethnic groups from the Djerba Island in Southeastern Tunisia. Despite the integration of the socio-culturally diverse civilizations over hundreds of years, ethnic separation remains a part of everyday life in Tunisia, mostly due to the different practices of the Muslim religion. Thus, the two populations maintain their separate cultures and ways of life although they share an agricultural and artisans economy. Despite their differences, both Arab and Berber groups show a high prevalence of T2DM, obesity, high consanguinity rate, and metabolic syndrome characteristics. Consequently, this environment provides the opportunity to investigate the effect of lifestyle on T2DM occurrence in association with genetic polymorphisms. We, therefore, randomly sampled the population to examine RFLPs at the INS, INSR, and IRS1 genes and the correlation between T2DM and particular environment risk factors for each ethnic group.

Materials and methods

Subjects

Unrelated men and women of Arab and Berber descent (172 Arab Tunisians and 100 Berber Tunisians) originating from the Island of Djerba were recruited from the Department of Endocrinology of Midoun and Houmet Essouk Hospital (for Arabs) and the Department of Endocrinology of Guellala and Sedwich Hospital (for Berbers). Healthy controls were recruited from the local villages throughout the Island. Arabs and Berbers were divided into two groups according to their diagnosis of T2DM. Inclusion criteria required that participants were of adult age, had lived on the island their entire lives, and that their partner was of the same ethnicity and had been born and raised on the island as well.

Clinical intake and medical histories

Clinical features and family history of diabetes were collected by questionnaire and interviews. Fasting glycemic status was checked for each participant. Randomly selected individuals had fasting glucose <6.1 mmol/l and did not suffer from any other disease. Weight and height were measured on barefoot and lightly clothed subjects. Body mass index (BMI; kg/m2) was calculated and obesity was defined as BMI ≥30 kg/m2.19 Hypertension was defined as a systolic pressure ≥140 mmHg or diastolic pressure ≥90 mmHg. The characteristics of the two groups are presented in Table 1. Venous blood samples were drawn for determination of plasma glucose and DNA extraction.

Table 1.

Sociodemographic and lifestyle characteristics of the different ethnic groups

Berber group
Arab group
Men
Women
Men
Women
T2DM Controls p T2DM Controls p T2DM Controls p T2DM Controls p
Total N = 26 N = 12 N = 34 N = 28 N = 44 N = 31 N = 58 N = 39
Age (years) 63.5 ± 11.1 55.42 ± 14.0 NS 55.9 ± 11.5 51.5 ± 13.3 NS 58.02 ± 10.7 54.2 ± 12.8 NS 57.9 ± 9.7 54.1 ± 12.5 NS
Low education level 34.62% 16.67% <0.05 67.65 % 71.43 % NS 34.1% 51.6% NS 60.34% 48.72% NS
Sedentary lifestyle 46.15% 50% NS 2.94% 0 % <0.05 65.91% 77.42% NS 13.79% 10.26% NS
BMI (Kg/m2) 26.71 ± 3.75 26.29 ± 5.86 NS 30.19 ± 5.69 30.46 ± 4.23 NS 26.70 ± 4.40 27.66 ± 4.28 NS 27.37 ± 5.68 27.98 ± 5.40 NS
Height (cm) 162 ± 8 163 ± 9 NS 155 ± 9 153 ± 7 NS 168 ± 7 167 ± 8 NS 161 ± 7 161 ± 9 NS
Weight (kg) 69.7 ± 8.7 68.9 ± 16.2 NS 72.0 ± 13.8 73.7 ± 13.5 NS 75.3 ± 11.6 79.0 ± 13.8 NS 71.3 ± 13.5 72.7 ± 13.0 NS
Low socioeconomic level 65.38% 33.33% <0.05 100% 96.43% NS 59.09% 51.61% NS 94.83% 84.62% NS
Low physical activity 34.61% 0% <0.05 20.59% 7.14% NS 20.45% 9.67% NS 24.13% 12.82% NS
Smoking habits 11.53% 25.00% NS 5.88% 0 NS 31.81% 32.25% NS 6.89% 2.56% NS
Alchohol consumption 11.53% 33.33% NS 0 0 NS 13.63% 9.67% NS 0% 0% NS
HTA 61.54% 8.33% <0.05 58.82% 14.29% <0.05 52.27% 9.68% <0.05 39.66% 25.64% NS
PD 8.73 ± 2.05 8.00 ± 0.60 NS 8.11 ± 0.76 8.17 ± 0.77 NS 8.02 ± 0.92 7.80 ± 0.70 NS 8.11 ± 0.61 8.07 ± 0.83 NS
PS 14.50 ± 1.90 12.75 ± 1.35 NS 14.14 ± 5.34 13.32 ± 1.92 NS 13.84 ± 1.39 12.87 ± 0.99 NS 13.75 ± 1.97 12.94 ± 1.23 NS
G0 1.62 ± 0.39 0.93 ± 0.08 NS 1.59 ± 0.15 0.93 ± 0.08 NS 1.71 ± 0.39 0.95 ± 0.08 NS 1.71 ± 0.48 0.93 ± 0.11 NS
GPP 2.61 ± 0.27 1.83 ± 0.22 NS 2.75 ± 0.87 1.79 ± 0.28 NS 2.53 ± 0.73 1.87 ± 0.28 NS 2.73 ± 0.29 1.77 ± 0.26 NS

Notes: Data are mean ± standard deviation or percentage frequency, age and sex are adjusted only for ethnicity; p < 0.05.

Abbreviations: BMI, body mass index; GO, fasting glycemia; GPP, 2-h glycemia; HTA, hypertension; NS, not significant; PD, diastolic pressure; PS, systolic pressure; T2DM, type 2 diabetes mellitus.

Questionnaires and interviews

For each subject, a questionnaire about lifestyle, age, education level, and physical activity was administered. Usual dietary intake was assessed with the use of a semi-quantitative food-frequency questionnaire (FFQ). The FFQ consisted of a list of foods with a standard serving size. Participants were asked to report their frequency of consumption of each food item during the previous year on a daily, weekly or monthly basis. Portion sizes of consumed foods were converted from household measures to grams. Each food and beverage was then coded according to the prescribed protocol and analyzed for content of energy and the other nutrients by weight using Bilnut software (INSERM; Nutrisoft, Cerelles, France), which was adapted for Tunisian foods.

Two measures of socioeconomic level status were used: 1) Level of education was measured as number of years spent in the education system, eg, primary school, secondary school, and high school, in contrast to nonreading analphabets. 2) Socioeconomic status was based on a questionnaire that asked about material possessions within the household, eg, water pipeline; two TV sets, toilet that can be flushed, bathroom, computer, gas/central heating, telephone, car, freezer, another apartment, video recorder.

For physical activity assessment, subjects completed a physical-activity-recall questionnaire. They were asked to record whether they are sleeping, sitting, standing, or watching television during each hour of the day. Subjects noted the time of day they started each new activity, body position during the activity (reclining, sitting, standing, or walking), effort (light, moderate, vigorous). They were asked about both leisure and occupational physical activity performed over the past week. For the past week, the average number of hours per week of each activity was calculated. The total hours of each activity were multiplied by the estimated metabolic cost (EMC) of the activity then, the physical activity level (PAL) was computed as the total energy expended over 24 hours divided by 24. Gender, age, height and body weight are the main determinants of basal metabolic rate (BMR). To estimate the BMR we used predictive equations based on these factors. By multiplying the PAL by the BMR, the total energy expenditure (TEE) was determined.

All procedures involved in the current study were reviewed and approved by the Ethics Committee of the Medicine University of Tunis. All study subjects signed informed consents.

Methods

Genomic DNA was isolated from peripheral blood by phenol extraction.20 Polymerase chain reaction (PCR) was performed using three primer pairs corresponding to respectively: the 3′ untranslated region of the INS gene, exon 8 of the INSR gene, and the region encompassing codon 972 of the IRS1 gene. Two sequence-specific oligonucleotide primers were used for the polymerase chain reaction: the 3′ primer (5′AGGCGTGGCATTGTGCCA3′) was used in combination with the 5′ primer (5′CTGGGAGGGGCTC-CAAGT 3′) for the insulin gene, for the receptor of the insulin we used the 3′ primer (5′CGGTCTTGTAAGGG-TAACTG3′) was used in combination with the 5′ primer (5’GAATTCACATTCCCAAGACA3’) and for the insulin receptor substrate 1 gene we used the 3′ primer (5′CTTCT-GTCAGGTGTCCATCC3′) was used in combination with the 5′ primer (5′TGGCGAGGTGTCCACGTAGC3′) These primers have been designed at Centro de Investigación Biomédica de Occidente in Mexico. Amplified products were digested with the corresponding restriction enzymes: PstI for the INS gene, NsiI for the INSR gene, and BstnI for the IRS1 gene amplicons. The digestion products were resolved by polyacrylamide gel electrophoresis and visualized by silver staining.21,22

Statistical analysis

The statistical software SPSS version 10.0 (SPSS Inc., Chicago, IL, USA) was used to analyze variables of the Arab and Berber groups relative to T2DM. The EPI INFO 6 package program (Centers for Disease Control and Prevention, Atlanta, GA, USA) was used to compare allelic and genotypic frequencies in diabetic patients and controls performing the Student’s t-test, the Pearson’s χ2 tests and the Fisher’s exact test (when genotype class was below 5). Odds ratios (OR) are given with their corresponding 95% confidence intervals (CI). A p value of <0.05 was considered to be statistically significant. Intakes were calculated with Bilnut software (Bilnut 4.0; Nutrisoft), which was adapted for Tunisian foods, for total energy, protein, carbohydrates (total, sucrose), fat (total, saturated, poly and monounsaturated), fiber, calcium, magnesium, sodium, phosphorus, animal to vegetable protein ratios, and polyunsaturated to saturated fat ratios.

Results

Sociodemographic and lifestyle characteristics

We compared the clinical (BMI and arterial pressure) characteristics of 162 T2DM patients and 110 healthy control subjects belonging to Berber and Arab groups of Djerba Island (Table 1). The mean age of the Arab T2DM group was 57.96 ± 10.09 and 54.13 ± 12.53 years for Arab controls. The mean age of the Berber T2DM group was 59.2 ± 11.85 and 52.70 ± 13.44 years for controls. Age was not significantly different for the groups as expected due to the matching design used. Results revealed a significant difference in educational levels between these two groups. In comparison with the Arabs, the Berbers had a lower level of education (Table 1) with a significant difference between Berber men and women. The Berber T2DM male’s socioeconomic level was significantly higher (p < 0.050) than controls. There was no significant difference in the Arab groups.

The prevalence of low physical activity was significantly higher among the Berber male group than the Arab male group; likewise, the prevalence of sedentary lifestyle was higher among the Berbers group compared to that of the Arabs. There was no difference in alcohol consumption and no significant difference in smoking habits between patients and controls (Table 1).

Caloric intakes

Table 2 presents mean dietary intake by ethnic groups for males and females, respectively. Mean caloric intakes among Arab males were 1846 ± 262 kcal. Caloric intakes among Berber males were 2039 ± 316 Kcal. For females, caloric intakes were 1833 ± 254 Kcal for Arabs and 1858 ± 239 kcal for Berbers. Mean caloric intakes for Arab subjects were 1839 ± 256 while it was 1927 ± 283 for Berber subjects. There were no significant ethnic differences in caloric intake in either sex group.

Table 2.

Dietary intakes in different ethnic groups

Arab group
Berber group
Men Women Total Men Women Total
Energy expenditure (cal/day) 2293 ± 230 1825 ± 154 2044 ± 304 2404 ± 574 1832 ± 188 2027 ± 454
Total energy intake (cal/day) 1966 ± 185 1922 ± 215 1943 ± 201 2069 ± 232 1951 ± 152 1991 ± 189
Protein (g/day) 56 ± 10 55 ± 11 55 ± 11 65 ± 143 57 ± 11 60 ± 13
Protein (% TEI) 12.1 ± 1.5 12.1 ± 1.8 12.1 ± 1.6 12.8 ± 1.7 12.3 ± 1.5 12.5 ± 1.5
AP/VP 0.81 ± 0.30 0.80 ± 0.33 0.81 ± 0.321 0.71 ± 0.44 0.65 ± 0.27 0.67 ± 0.30
Fat (g/day) 68 ± 18 70 ± 14 69 ± 161 83 ± 193 70 ± 14 78 ± 17
Fat (% TEI) 33.5 ± 6.0 34.5 ± 3.8 34.0 ± 4.91 36.7 ± 4.7 36.4 ± 4.4 36.5 ± 4.5
SFA (g/day) 17.4 ± 5.8 18.2 ± 4.9 17.7 ± 5.3 18.8 ± 4.8 17.9 ± 5.6 18.2 ± 5.3
SFA (% TEI) 7.8 ± 2.3 8.5 ± 2.0 8.2 ± 2.2 8.2 ± 1.5 8.2 ± 2.3 8.2 ± 2.0
MUFA (g/day) 43.6 ± 12.1 43.3 ± 9.7 43.4 ± 10.71 53.5 ± 13.43 48.4 ± 10.5 50.1 ± 11.7
MUFA (% TEI) 19.8 ± 4.7 20.1 ± 3.1 20.0 ± 3.91 23. ± 3.53 22.2 ± 3.72 22.5 ± 3.6
PUFA (g/day) 7.5 ± 1.9 8.2 ± 2.8 7.9 ± 2.41 10.7 ± 5.63 9.2 ± 3.1 9.7 ± 4.1
PUFA (% TEI) 3.4 ± 0.8 3.8 ± 1.1 3.6 ± 1.01 4.1 ± 1.1 4.2 ± 1.4 4.2 ± 1.3
PUFA/SFA 0.47 ± 0.13 0.46 ± 0.13 0.47 ± 0.131 0.51 ± 0.14 0.55 ± 0.202 0.54 ± 0.18
Cholesterol (mg/day) 127.4 ± 100.1 101.4 ± 76.1 113.6 ± 88.1 94.3 ± 84.1 109.8 ± 98.9 104.6 ± 93.5
Carbohydrates (g/day) 251 ± 43 244 ± 44 248 ± 42 253 ± 35 236 ± 28 242 ± 31
Sucrose (g/day) 34 ± 22 33 ± 22 33 ± 221 18 ± 123 25 ± 23 23 ± 20
Fibres (g/day) 25 ± 5 24 ± 7 24 ± 6 29 ± 73 25 ± 5 27 ± 7

Notes:

1

p < 0.05 between Arab and Berber groups;

2

p < 0.05 between Arab and Berber women;

3

p < 0.05 between Arab and Berber men.

Abbreviations: AP/VP, animal protein/vegetal protein ratio; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid; PUFA, polyunsaturated fatty acid; TEI, total energy intake; PUFA/SFA = poly unsaturated fatty acid-saturated fatty acid ratio.

Macronutrient intakes

Average protein intake for each group was 56 g, 65 g, 55 g, and 57 g for Arab men, Berber men, Arab women, and Berber women, respectively (Table 2). There was no significant difference among women of either groups when compared by ethnicity but there was a significant difference (p < 0.02) between Arab and Berber men. Nevertheless, the animal protein to vegetable protein ratio was significantly greater in the Arab group (men and women) than Berber group (p < 0.03).

Average carbohydrate consumption showed no statistical significance across groups when compared by ethnicity. However the Arab group consumed more sucrose than the Berber group (p < 0.02) and the Berber group consumed more fiber than the Arab group (p < 0.02). There was a positive correlation between calories and fiber intake (r = 0.55; p < 0.001) and a negative correlation between fiber and sucrose intake (r = −0.33; p < 0.001).

Prevalence of overweight and of reported morbidity

Prevalence of overweight was higher among the Berber women than among the Arabs, but the difference was not significant between T2DM cases and controls (Table 1). There was no significant difference in height and weight between the two groups. There was a significant difference in hypertension in the two groups. There was no significant difference between diastolic and systolic pressure.

Comparison between Arab and Berber allelic and genotypic distribution

Polymorphism of three genes was analyzed in 162 patients and 110 controls: PstI polymorphism in nucleotide 1367 of the 3′ untranslated regions of the insulin gene,23 NsiI polymorphism in exon 8 at nucleotide 6224 of the insulin receptor gene24 and BstnI polymorphism at codon 972 in the coding region of the insulin receptor substrate 1 gene.25

To assess associations between these described polymorphisms and T2DM, we analyzed the allelic and genotypic frequencies in patients and healthy controls belonging to Arab and Berber subgroups in Djerba. The genotype distributions for these SNPs were found to be in Hardy–Weinberg equilibrium for these populations. The allelic distributions for PstI, NsiI, and BstnI polymorphisms in cases and control groups are summarized in Table 3. The comparison of the allelic distribution between the four subgroups has demonstrated a significant difference (p < 0.05) for the NsiI polymorphism of the INSR gene and BstnI polymorphism of IRS1 gene only for the Berber group. The effect of the NsiI G and A alleles (ORINSR Nsil G = 0.52, 95% CI: 0.26–2.01; p = 0.037 and ORINSR Nsil A = 1.93, 95% CI: 0.99–3.79; p = 0.037, respectively) seems to be protective against T2DM in Berbers only.

Table 3.

Allelic distribution of Psti, Nsi, and Bstni polymorphisms in Arabs and Berbers of Djerba Island

Djerbian diabetic patients N = 162 Djerbian controls N = 110
Gene symbol Alleles Arabs N = 102% Berbers N = 60% Arabs N = 70% Berbers N = 40% Arab patients vs Arab controls p value, OR (confidence Interval) Berber patients vs Berber controls p value, OR (confidence Interval)
Pst1
INS G 93.63 92.5 91.43 87.5 NS NS
A 6.37 7.5 8.57 12.5 NS NS
Nsi1
INSR G 72.55 60.83 74.28 75 NS p = 0.037; OR = 0.52 (0.26–2.01)
A 27.45 39.17 25.72 25 NS p = 0.037; OR = 1.93 (0.99–3.79)
Bstn1
IRS1 G 83.82 89.17 84.28 81.25 NS NS
A 16.18 10.83 17.72 18.75 NS NS

Notes: Nominal value for comparison, p ≤ 0.05; degree of freedom = 1.

Abbreviations: NS, not significant; OR, odds ratio.

Genotype distribution for these polymorphisms in T2DM cases and control groups were summarized in Table 4. It appeared that INSR NsiI (G/G) and IRS1BstnI (G/A) SNPs could be protective against T2DM (ORINSR Nsil G/G = 0.48, 95% CI: 0.17–2.05; p = 0.04 and OR IRS1BstnI G/A = 0.37, 95% CI: 0.14–2.02; p = 0.032, respectively) in Berbers, since these genotypes were more frequent in healthy controls than in Berber T2DMs (67% versus 57%, 5% for NsiI [G/G] and 18.33% versus 37.5% for BstnI [G/A]). The PstI SNP was not associated with T2DM in either of these two subgroups.

Table 4.

Genotypic distribution of, PstI, NsiI, and BstnI polymorphisms in Arabs and Berbers of Djerba Island

Diabetic patients N = 162 Controls N = 110
Gene symbol Genotypes Arabs N = 102% Berbers N = 60% Arabs n = 70% Berbers n = 40% Arab diabetics vs Arab controls p value; OR (confidence interval) Berber diabetics vs Berber controls p value; OR (confidence interval)
PstI
INS G/G 87.25 85 82.86 75 NS NS
G/A 12.75 15 17.14 25 NS NS
A/A 0 0 0 0 NS NS
NsiI p = 0.04; OR = 0.43; (0.17–2.05)
INSR G/G 51.96 36.67 54.28 57.5 NS
G/A 41.17 48.33 40 35 NS NS
A/A 6.87 15 5.72 7.5 NS NS
BstnI
IRS1 G/G 67.65 80 68.57 62.5 NS NS
G/A 32.35 18.33 31.43 37.5 NS p = 0.032; OR = 0.37; (0.14–2.02)
A/A 0 1.67 0 0 NS
NS

Notes: Nominal value for comparison, p ≤ 0.05; degree of freedom = 1.

Abbreviation: NS, not significant.

Discussion

In the present work, we investigated the effect of lifestyle and socioeconomic factors on T2DM occurrence, in association with genetic polymorphisms. Our choice of Arab and Berber ethnic groups of Djerba Island is based on previous observations indicating that these populations, though living in the same environment and displaying the same genetic background, have different lifestyles in terms of activity, culture, lifestyle, and nutrition. The Berber and Arab communities, which constitute a minority of the Tunisian population, are isolated from the other two population groups who have settled in the villages of the Djerba Island.26,27 We have focused on the PstI, NsiI, and BstnI, restrictions sites of the insulin, insulin receptor, and insulin receptor substrate 1 genes, respectively. These genes are known to play a key role in glucose and lipid metabolism.

We examined possible correlations between these polymorphisms and the predisposition to T2DM. We have shown that the healthy Arab and Berber populations display the same allelic and genotypic distributions and that the Pst1 polymorphism of the INS gene is not associated with T2DM in either studied groups. In fact, it has been reported that polymorphisms in a variable number of tandem repeat (VNTR) sequences in INS, the insulin gene, cause type 1 diabetes.28 This region regulates insulin gene transcription thus providing a mechanism whereby this gene may be related to hyperinsulinemia, and thereby to T2DM or metabolic syndrome. Polymorphisms in INS are associated with T2DM in some populations,29 but not in others.30

On the other hand, we found an association of NsiI insulin receptor gene polymorphism with T2DM in the Berber group. In the literature, mutations of the insulin-receptor gene have been reported in patients with the rare syndrome of severe insulin resistance that contributes to noninsulin-dependent diabetes mellitus.31 Polymorphisms in this receptor gene are associated in some populations with T2DM, insulin resistance,32 and hypertension.

Finally we have shown that the BstnI Gly 972 Arg polymorphism of the insulin receptor substrate 1 is associated with T2DM only among Berbers. As reported in the literature, mutations of the insulin-receptor substrate gene have been described in patients with the rare syndrome of severe insulin resistance that contributes to noninsulin-dependent diabetes mellitus.33,34 Indeed several studies have reported a higher frequency of the IRS1 Arg 972 polymorphism among T2DM patients, while others have reported a weak association or its absence between this variant and T2DM.35 The IRS1 Arg 972 polymorphism is absent in Pima Indians and other subpopulations.3638 In both diabetic and control Japanese populations, the prevalence of the Arg 972 polymorphism appears to be lower than that observed in Caucasian populations.39 These results may account for the ethnic differences in the genetic background for T2DM. There were no differences between males and females in their respective clinical and biochemical findings, although there was a slightly higher prevalence of obesity in Berber women (based on BMI, height, and weight data), also characterized by a low education level and a low activity or sedentary lifestyle. A significant difference (p < 0.05) in education level, sedentary lifestyle, low physical activity, and socioeconomic levels between healthy and diabetic Berber male subjects was found, suggesting that correlations may exist among these factors and risk for T2DM among Berbers. For the Arab group, no significant difference was observed between healthy and T2DM subjects. Hypertension was associated with T2DM in both groups.

To explain the differences between our results on the two Djerban groups and to distinguish genetic factors from the influence of the environment factors, we considered the nongenetic factors, ie, factors that can be controlled by behavior, (diet, activity levels/sedentary lifestyle, and obesity) implicated in the etiology of diabetes. These environmental factors are significantly different between Arabs and Berbers. The presence of some risk factors for T2DM in diabetic Berbers are related to lifestyle such as a more sedentary lifestyle, lower levels of physical activity, and lower levels of education for diabetic males who do not complete primary education and who are of a lower socioeconomic status. Berbers who have an underprivileged social background have higher rates of mortality and morbidity compared to the Arabs; they retain traditional behaviors that result in T2DM.40 Social status was found to be a risk factor for T2DM in other populations such as those in urban Sweden.41 In fact, our samples were obtained from public hospitals in villages where most patients are from a lower socioeconomic background.

We have shown that in the Berber group, low levels of education, socioeconomic status and limited physical activity are risk factors for T2DM. INSR gene NsiI G/G and IRS1 gene BstnI G/A genotype are protective against T2DM. For the Arab group, these same factors are not significantly associated to T2DM. More investigation is needed to analyse the occurrence of T2DM in Arabs to determine the source of their T2DM protection, or other environmental and genetic risk factors. To our knowledge this is the first study which compares the dietary intake of Arab and Berber people. The inclusion criteria of this study reduced the influence of the socioeconomic level and acculturation on the food choices. These conditions were often considered as factors of variability. Low education level is a factor that exacerbates the problem of obesity in Tunisia. Women without education do not recognize the risks and health consequences associated with obesity. It is more worrisome that these women (and their male partners) consider fatness and obesity to be desirable since culturally these traits have been associated with higher social status, fertility and prosperity.

In conclusion, these results focus on some of the risk factors leading to T2DM and on the possible interactions between genetic and environmental factors. Ethnicity and differences in education level play an important role in the occurrence of the disease.42 Berbers may constitute a group at higher risk for developing T2DM and hypertension, due to their nutritional habits. Lack of adequate dietary intake, accompanied by obesity, low physical activity and low socioeconomic levels may combine to cause this disease. These findings suggest that appropriate dietary interventions and education may ameliorate nutritional deficiencies and improve healthy behavioral lifestyles.

Acknowledgments

We are grateful to all donors of Djerba Island hospital for their participation in the study, and the collection of blood samples. We also thank all members of the Centro de Investigación Biomédica de Occidente, Instituto Mexicano Del Seguro Social, Guadalajara, Jalisco in México for their considerable help in the genetic study. We report no conflicts of interest in this work.

References

  • 1.McCarthy MI, Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab. 2002;283:217–225. doi: 10.1152/ajpendo.00099.2002. [DOI] [PubMed] [Google Scholar]
  • 2.Morton N, Lio E. Oligogenic linkage and map integration. In: Pawlowitzki IH, Edwards JH, Thompson EA, editors. Genetic Mapping of Disease Genes. 1st edition. San Diego, CA: Academic Press; 1997. pp. 17–21. [Google Scholar]
  • 3.De Meyts P. The diabetogenes concept of NIDDM. Adv Exp Med Biol. 1993;334:89–100. doi: 10.1007/978-1-4615-2910-1_7. [DOI] [PubMed] [Google Scholar]
  • 4.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197. doi: 10.2337/diacare.20.7.1183. [DOI] [PubMed] [Google Scholar]
  • 5.Moller DE, Bjørbæk C, Vidal Puig A. Candidate genes for insulin resistance. Diabetes Care. 1996;19:396–400. doi: 10.2337/diacare.19.4.396. [DOI] [PubMed] [Google Scholar]
  • 6.Hoban PR, Kelsey AM. Pst I polymorphism within the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction. Nucleic Acids Res. 1991;19:4576. doi: 10.1093/nar/19.16.4576-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Taylor SI, Kadowaki T, Kadowaki HD, Cama C, Keon M. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care. 1990;13:257–279. doi: 10.2337/diacare.13.3.257. [DOI] [PubMed] [Google Scholar]
  • 8.Taylor SI. Insulin action, insulin resistance and type 2 diabetes mellitus. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Diseases. 8th edition. New York, NY: McGraw-Hill; 2001. pp. 1433–1470. [Google Scholar]
  • 9.Bennett ST, Todd AJ. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet. 1996;30:343–370. doi: 10.1146/annurev.genet.30.1.343. [DOI] [PubMed] [Google Scholar]
  • 10.Bennett ST, Lucassen AM, Gough SC, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 1995;9:284–292. doi: 10.1038/ng0395-284. [DOI] [PubMed] [Google Scholar]
  • 11.Schrader AP, Zee RY, Morris BJ. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives. Clin Genet. 1996;49:74–78. doi: 10.1111/j.1399-0004.1996.tb04331.x. [DOI] [PubMed] [Google Scholar]
  • 12.Imai YA, Fusco Y, Suzuki, et al. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79:1655–1658. doi: 10.1210/jcem.79.6.7989470. [DOI] [PubMed] [Google Scholar]
  • 13.Baroni MG, Arca F, Sentinelli F, et al. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia. 2001;44:367–372. doi: 10.1007/s001250051628. [DOI] [PubMed] [Google Scholar]
  • 14.Gharbi M, Akrout M, Zouari B. Prevalence and risk factors of non-insulin-dependent diabetes mellitus in the rural and urban population of Tunisia. Rev Epidemiol Sante Publique. 2002;503:49–55. [PubMed] [Google Scholar]
  • 15.Arfa I, Abid A, Malouche D, et al. Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia. Postgrad Med J. 2007;833:48–51. doi: 10.1136/pgmj.2006.053744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sánchez-Corona J, Flores-Martínez SE, Machorro-Lazo MV, et al. Polymorphisms in candidate genes for type 2 diabetes mellitus in a Mexican population with metabolic syndrome findings. Diabetes Res Clin Pract. 2004;63:47–55. doi: 10.1016/j.diabres.2003.08.004. [DOI] [PubMed] [Google Scholar]
  • 17.Vasarova de Courten B, de Courten M, Hanson RL, et al. Higher prevalence of type 2 diabetes metabolic syndrome and cardiovascular diseases in gypsies than in non-gypsies in Slovakia. Diabetes Res Clin Pract. 2003;62:95–103. doi: 10.1016/s0168-8227(03)00162-1. [DOI] [PubMed] [Google Scholar]
  • 18.Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:1–27. doi: 10.1002/dmr.5610060101. [DOI] [PubMed] [Google Scholar]
  • 19.Arroyo P, Pardio J, Fernandez V, Vargas-Ancona L, Canul G, Loria A. Obesity and cultural environment in Yucatan region. Nutr Rev. 1999;57(5 Pt 2):S78–S82. doi: 10.1111/j.1753-4887.1999.tb01793.x. [DOI] [PubMed] [Google Scholar]
  • 20.Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:298–302. [PubMed] [Google Scholar]
  • 21.Sambrook J, Fritsch EF, Maniatis T, editors. Molecular Cloning: A Laboratory Manual. 2nd edition. New York, NY: Cold Spring Harbor Laboratory Press; 1989. pp. 9.1–9.62. [Google Scholar]
  • 22.Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  • 23.Hoban PR, Kelsey AM. PstI polymorphism within the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction (INS) Nucleic Acids Res. 1991;19:45–76. doi: 10.1093/nar/19.16.4576-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Schrader AP, Zee RY, Morris BJ. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives. Clin Genet. 1996;49:74–78. doi: 10.1111/j.1399-0004.1996.tb04331.x. [DOI] [PubMed] [Google Scholar]
  • 25.Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993;342:828–832. doi: 10.1016/0140-6736(93)92694-o. [DOI] [PubMed] [Google Scholar]
  • 26.Cherni L, Pereira L, Goios A, et al. Y-chromosomal STR haplotypes in three ethnic groups and one cosmopolitan population from Tunisia. Forensic Sci Int. 2005;152:95–99. doi: 10.1016/j.forsciint.2005.02.007. [DOI] [PubMed] [Google Scholar]
  • 27.Loueslati B, Cherni L, Khodjet-Elkhil H, et al. Islands inside an island: reproductive isolates on Jerba island. Am J Hum Biol. 2006;18:149–153. doi: 10.1002/ajhb.20473. [DOI] [PubMed] [Google Scholar]
  • 28.Bennett ST, Lucassen AM, Gough SC, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 1995;9:284–292. doi: 10.1038/ng0395-284. [DOI] [PubMed] [Google Scholar]
  • 29.Morgan R, Bishop A, Owens DR, Luzio SD, Peters JR, Rees A. Allelic variants at insulin-receptor and insulin gene loci and susceptibility to NIDDM in Welsh population. Diabetes. 1990;39:1479–1484. doi: 10.2337/diab.39.12.1479. [DOI] [PubMed] [Google Scholar]
  • 30.Given BD, Mako ME, Tager HS, et al. Diabetes due to secretion of an abnormal insulin. N Engl J Med. 1980;302:129–135. doi: 10.1056/NEJM198001173020301. [DOI] [PubMed] [Google Scholar]
  • 31.Seino S, Bell GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun. 1989;159:312–316. doi: 10.1016/0006-291x(89)92439-x. [DOI] [PubMed] [Google Scholar]
  • 32.Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L. Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke. 2001;32:1098–1103. doi: 10.1161/01.str.32.5.1098. [DOI] [PubMed] [Google Scholar]
  • 33.Baroni MG, Arca M, Sentinelli F, et al. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia. 2001;44:367–372. doi: 10.1007/s001250051628. [DOI] [PubMed] [Google Scholar]
  • 34.Clausen JO, Hansen T, Bjorbaek C, et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet. 1995;346:397–402. doi: 10.1016/s0140-6736(95)92779-4. [DOI] [PubMed] [Google Scholar]
  • 35.Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 1999;48:1868–1872. doi: 10.2337/diabetes.48.9.1868. [DOI] [PubMed] [Google Scholar]
  • 36.Chuang LM, Lai CS, Yeh JI, Wu HP, Tai TY, Lin BJ. No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care. 1996;19:446–449. doi: 10.2337/diacare.19.5.446. [DOI] [PubMed] [Google Scholar]
  • 37.van Dam RM, Hoebee B, Seidell JC, Schaap MM, Blaak EE, Feskens EJ. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with type 2 diabetes mellitus in two population-based studies. Diabet Med. 2004;21:752–758. doi: 10.1111/j.1464-5491.2004.01229.x. [DOI] [PubMed] [Google Scholar]
  • 38.Celi FS, Silver K, Walston J, Knowler WC, Bogardus C, Shuldiner AR. Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J Clin Endocrinol Metab. 1995;80:2827–2829. doi: 10.1210/jcem.80.9.7673431. [DOI] [PubMed] [Google Scholar]
  • 39.Ura S, Araki E, Kishikawa H, et al. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia. 1996;39:600–608. doi: 10.1007/BF00403308. [DOI] [PubMed] [Google Scholar]
  • 40.Yacoubi Loueslati B, Ennafaa H, Ben Amor M, et al. [Mitochondrial DNA polymorphism reveals a genetic differentiation between ethnic groups in the population of Jerba] Arch Inst Pasteur Tunis. 1998;75:9–18. [PubMed] [Google Scholar]
  • 41.Andersson CM, Bjaras G, Tillgren P, Ostenson G. Local media monitoring in process evaluation. Experiences from the Stockholm Diabetes Prevention Programme. J Health Commun. 2007;3:269–283. doi: 10.1080/10810730701266307. [DOI] [PubMed] [Google Scholar]
  • 42.Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol. 2005;99:1193–1204. doi: 10.1152/japplphysiol.00160.2005. [DOI] [PubMed] [Google Scholar]

Articles from Pharmacogenomics and personalized medicine are provided here courtesy of Dove Press

RESOURCES